Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VSTM
Stock Latest News
Company Announcements
Verastem’s Phase 3 Study Update: A Potential Game-Changer in Ovarian Cancer Treatment
3d ago
VSTM
Premium
Company Announcements
Verastem’s Promising KRAS G12D Inhibitor Study: A Potential Game-Changer in Cancer Treatment
9d ago
VSTM
Premium
The Fly
Verastem publishes RAMP 201 trial data in Journal of Clinical Oncology
16d ago
VSTM
Premium
Company Announcements
Verastem’s Phase 3 Study on Avutometinib and Defactinib: A Potential Game-Changer for Ovarian Cancer Treatment
23d ago
VSTM
Premium
Company Announcements
Verastem’s Promising Phase 3 Study on Recurrent Ovarian Cancer
25d ago
VSTM
Premium
The Fly
Verastem announces Nature Medicine publication of FRAME results
27d ago
VSTM
Premium
Company Announcements
Verastem’s Promising Phase 3 Study on Avutometinib and Defactinib in Ovarian Cancer
27d ago
VSTM
Premium
The Fly
Verastem price target lowered to $12 from $16 at RBC Capital
1M ago
VSTM
Premium
The Fly
Closing Bell Movers: FedEx slips 5% after results and guidance
1M ago
BB
FDX
Premium
The Fly
Verastem announces first patient dosed with VS-7375
1M ago
VSTM
Premium
Ratings
Verastem’s Strategic Growth and Promising Clinical Data Drive Buy Rating
2M ago
VSTM
Premium
Ratings
Promising Clinical Developments and Strong Valuation Support Buy Rating for Verastem
2M ago
VSTM
Premium
Ratings
Verastem’s Promising Clinical Advances and Strategic Developments Justify Buy Rating
2M ago
VSTM
Premium
Company Announcements
Verastem Announces Strategic Plans in Investor Webcast
2M ago
8K
VSTM
Premium
Company Announcements
Verastem Announces Promising Phase 1 Study Results
2M ago
8K
VSTM
Premium
The Fly
Verastem announces updated data from GenFleet’s Phase 1 GFH375 study
2M ago
VSTM
Premium
Company Announcements
Verastem Announces Positive RAMP 205 Trial Results
2M ago
8K
VSTM
Premium
The Fly
Verastem announces positive Phase 1/2 safety and efficacy results in PDAC
2M ago
VSTM
Premium
Ratings
Verastem’s Strategic Focus and FDA Approval Drive Buy Rating
2M ago
VSTM
Premium
The Fly
Verastem files to sell 3.43M shares of common stock for holders
3M ago
VSTM
Premium
The Fly
Verastem reports Q1 adjusted EPS (79c), two estimates (77c)
3M ago
VSTM
Premium
The Fly
Verastem price target raised to $13 from $12 at B. Riley
3M ago
VSTM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
